Xu Guohui, Wang Xiaolin, Deng Chao, Teng Xiaomei, Suuronen Erik J, Shen Zhenya, Zhong Zhiyuan
Biomedical Polymers Laboratory, and Jiangsu Key Laboratory of Advanced Functional Polymer Design and Application, College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Suzhou 215123, People's Republic of China.
Cardiovascular Surgery Department, The First Affiliated Hospital of Soochow University, Suzhou 215012, People's Republic of China.
Acta Biomater. 2015 Mar;15:55-64. doi: 10.1016/j.actbio.2014.12.016. Epub 2014 Dec 26.
Injectable biodegradable hybrid hydrogels were designed and developed based on thiolated collagen (Col-SH) and multiple acrylate containing oligo(acryloyl carbonate)-b-poly(ethylene glycol)-b-oligo(acryloyl carbonate) (OAC-PEG-OAC) copolymers for functional cardiac regeneration. Hydrogels were readily formed under physiological conditions (37°C and pH 7.4) from Col-SH and OAC-PEG-OAC via a Michael-type addition reaction, with gelation times ranging from 0.4 to 8.1 min and storage moduli from 11.4 to 55.6 kPa, depending on the polymer concentrations, solution pH and degrees of substitution of Col-SH. The collagen component in the hybrid hydrogels retained its enzymatic degradability against collagenase, and the degradation time of the hydrogels increased with increasing polymer concentration. In vitro studies showed that bone marrow mesenchymal stem cells (BMSCs) exhibited rapid cell spreading and extensive cellular network formation on these hybrid hydrogels. In a rat infarction model, the infarcted left ventricle was injected with PBS, hybrid hydrogels, BMSCs or BMSC-encapsulating hybrid hydrogels. Echocardiography demonstrated that the hybrid hydrogels and BMSC-encapsulating hydrogels could increase the ejection fraction at 28 days compared to the PBS control group, resulting in improved cardiac function. Histology revealed that the injected hybrid hydrogels significantly reduced the infarct size and increased the wall thickness, and these were further improved with the BMSC-encapsulating hybrid hydrogel treatment, probably related to the enhanced engraftment and persistence of the BMSCs when delivered within the hybrid hydrogel. Thus, these injectable hybrid hydrogels combining intrinsic bioactivity of collagen, controlled mechanical properties and enhanced stability provide a versatile platform for functional cardiac regeneration.
基于硫醇化胶原蛋白(Col-SH)和含多个丙烯酸酯的低聚(丙烯酰碳酸酯)-b-聚(乙二醇)-b-低聚(丙烯酰碳酸酯)(OAC-PEG-OAC)共聚物,设计并开发了可注射的生物可降解混合水凝胶,用于功能性心脏再生。在生理条件(37°C和pH 7.4)下,Col-SH和OAC-PEG-OAC通过迈克尔型加成反应很容易形成水凝胶,凝胶化时间为0.4至8.1分钟,储能模量为11.4至55.6 kPa,这取决于聚合物浓度、溶液pH值和Col-SH的取代度。混合水凝胶中的胶原蛋白成分保留了其对胶原酶的酶促降解性,水凝胶的降解时间随着聚合物浓度的增加而延长。体外研究表明,骨髓间充质干细胞(BMSCs)在这些混合水凝胶上表现出快速的细胞铺展和广泛的细胞网络形成。在大鼠梗死模型中,向梗死的左心室注射磷酸盐缓冲盐水(PBS)、混合水凝胶、BMSCs或包裹BMSCs的混合水凝胶。超声心动图显示,与PBS对照组相比,混合水凝胶和包裹BMSCs的水凝胶在28天时可提高射血分数,从而改善心脏功能。组织学显示,注射的混合水凝胶显著减小了梗死面积并增加了壁厚,而包裹BMSCs的混合水凝胶治疗进一步改善了这些指标,这可能与BMSCs在混合水凝胶中递送时的植入和持久性增强有关。因此,这些结合了胶原蛋白固有生物活性、可控机械性能和增强稳定性的可注射混合水凝胶为功能性心脏再生提供了一个通用平台。